Fig. 2. Potential processes after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in people with obesity. COVID-19, coronavirus disease 2019. References: ↓lung function,
51 interstitial lung damage
68; ↑metabolic rate,
69 ↑tissue hypoxia
70; ↑blood glucose concentration,
46 ↑glucotoxicity
71; ↑thromboembolic risk,
72 deep vein thrombosis & pulmonary embolism
73; immune modulation
45; ↑inflammation,
42-
44,
60 ↑systemic inflammation
42-
44,
60; ↑cytokine production,
42,
43,
60 ↑oxidative stress and cytokine storm.
74
